Clariant to Acquire Chinese Healthcare Packaging Firm

In a deal expected to be completed in the fourth quarter, Swiss specialty chemicals producer Clariant plans to acquire Hong Kong-based healthcare packaging manufacturer VitaPac.

The privately owned company has sales of 4 million Swiss francs, 80 employees and a production site in Dongguan, China.

VitaPac develops and manufactures high-end protective packaging solutions for the pharmaceutical, neutraceutical and food industries as well as for the logistics and electronics sectors, mainly in Asia-Pacific.

Focusing on active sorbents, the Chinese company has a leading market position for desiccant packets for moisture adsorption, Clariant said, adding that VitaPac maintains a Drug Master File (DMF) with the FDA, and its products comply with all pertinent regulations for use in direct contact with food and drugs.

The acquisition is designed to complement the portfolio of Clariant's Medical Specialties business line within its Masterbatches business unit. The Swiss chemical producer said the buy will help it to gain increased market share in important emerging markets in Asia but also in other regions.

Clariant said the acquired Chinese plant at Dongguan plant will enlarge its global footprint, furthering the reach to multinational pharmaceutical industry customers.

Interview

Innovation at the Intersection of AI
Digital Potential in Key Business Areas

Innovation at the Intersection of AI

Stefan Guertzgen spoke with John Banovetz, Chief Technology Officer at 3M, about the role of digital transformation in achieving the company's objectives.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences

The Start-up Platform for Chemistry & Life Sciences

The tasks range from employee protection, site security and crisis management to IT, OT and production security.

most read

Photo
24.01.2025 • News

CEFIC Publishes 2024 Facts and Figures Report

CEFIC , the European Chemical Industry Council, has published its 2024 Facts & Figures report, which reinforces the need to take bold and urgent action to secure Europe’s industrial future, not only to implement the Green Deal but also to prevent further de-industrialization in Europe.

Photo
27.03.2025 • News

Moeve Joins Global Impact Coalition

The Global Impact Coalition (GIC), a collaborative platform led by CEOs and focused on achieving a net-zero chemicals future, has announced the addition of Moeve as its newest member.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.